174 related articles for article (PubMed ID: 25810462)
1. Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study.
Child CJ; Conroy D; Zimmermann AG; Woodmansee WW; Erfurth EM; Robison LL
Eur J Endocrinol; 2015 Jun; 172(6):779-90. PubMed ID: 25810462
[TBL] [Abstract][Full Text] [Related]
2. Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study.
Child CJ; Zimmermann AG; Woodmansee WW; Green DM; Li JJ; Jung H; Erfurth EM; Robison LL;
Eur J Endocrinol; 2011 Aug; 165(2):217-23. PubMed ID: 21646285
[TBL] [Abstract][Full Text] [Related]
3. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
[TBL] [Abstract][Full Text] [Related]
4. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
Krzyzanowska-Mittermayer K; Mattsson AF; Maiter D; Feldt-Rasmussen U; Camacho-Hübner C; Luger A; Abs R
J Clin Endocrinol Metab; 2018 Feb; 103(2):523-531. PubMed ID: 29228199
[TBL] [Abstract][Full Text] [Related]
5. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.
Woodmansee WW; Zimmermann AG; Child CJ; Rong Q; Erfurth EM; Beck-Peccoz P; Blum WF; Robison LL;
Eur J Endocrinol; 2013 Apr; 168(4):565-73. PubMed ID: 23359434
[TBL] [Abstract][Full Text] [Related]
6. Patients with craniopharyngiomas: therapeutical difficulties with growth hormone.
Cannavò S; Marini F; Trimarchi F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):56-60. PubMed ID: 19020388
[TBL] [Abstract][Full Text] [Related]
7. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
8. Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database.
Maiter D; Abs R; Johannsson G; Scanlon M; Jönsson PJ; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Aug; 155(2):253-60. PubMed ID: 16868138
[TBL] [Abstract][Full Text] [Related]
9. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
[TBL] [Abstract][Full Text] [Related]
10. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.
Abs R; Bengtsson BA; Hernberg-Stâhl E; Monson JP; Tauber JP; Wilton P; Wüster C
Clin Endocrinol (Oxf); 1999 Jun; 50(6):703-13. PubMed ID: 10468941
[TBL] [Abstract][Full Text] [Related]
11. Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?
Hatrick AG; Boghalo P; Bingham JB; Ayres AB; Sonksen PH; Russell-Jones DL
Eur J Endocrinol; 2002 Jun; 146(6):807-11. PubMed ID: 12039701
[TBL] [Abstract][Full Text] [Related]
12. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
Smith TR; Cote DJ; Jane JA; Laws ER
J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
[TBL] [Abstract][Full Text] [Related]
13. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Aug; 100(8):3132-9. PubMed ID: 26057181
[TBL] [Abstract][Full Text] [Related]
14. GH therapy and cancer risk in hypopituitarism: what we know from human studies.
Pekic S; Popovic V
Eur J Endocrinol; 2013 Nov; 169(5):R89-97. PubMed ID: 23935131
[TBL] [Abstract][Full Text] [Related]
15. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.
Svensson J; Bengtsson BA; Rosén T; Odén A; Johannsson G
J Clin Endocrinol Metab; 2004 Jul; 89(7):3306-12. PubMed ID: 15240607
[TBL] [Abstract][Full Text] [Related]
16. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
17. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
[TBL] [Abstract][Full Text] [Related]
18. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
19. Overall and cause-specific mortality in GH-deficient adults on GH replacement.
Gaillard RC; Mattsson AF; Akerblad AC; Bengtsson BÅ; Cara J; Feldt-Rasmussen U; Koltowska-Häggström M; Monson JP; Saller B; Wilton P; Abs R
Eur J Endocrinol; 2012 Jun; 166(6):1069-77. PubMed ID: 22457236
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
